Campbell & Co. Investment Adviser »

BioCryst Pharmaceuticals shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2025-09-30 $832k 110k 7.59
2025-06-30 $3.7M 413k 8.96
2025-03-31 $163k 22k 7.50

More positions owned by Campbell & Co. Investment Adviser

Wheaton Precious Metals Corp Common Stock (WPM)
Rio Tinto Adr (RIO)
Sprouts Farmers Market Common Stock (SFM)
PTC Common Stock (PTC)
Agnico Eagle Mines Common Stock (AEM)
OGE Energy Corp Common Stock (OGE)
Paychex Common Stock (PAYX)
CMS Energy Corp Common Stock (CMS)
Royal Gold Common Stock (RGLD)
Logitech International SA Common Stock (LOGI)
Franklin Resources Common Stock (BEN)
Meta Platforms Common Stock (META)
Graphic Packaging Holding Common Stock (GPK)
Kinder Morgan Common Stock (KMI)
Pan American Silver Corp Common Stock (PAAS)

View all positions for Campbell & Co. Investment Adviser

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
Deerfield Management Company
State Street Corporation
Kynam Capital Management
UBS Group
Alkeon Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Hood River Capital Management
Nuveen
Assenagon Asset Management

View all funds holding BioCryst Pharmaceuticals